Bill: Do you support "Medicare Prescription Drug Price Negotiation Act of 2019" (HR 275) (Welch)?

Yes. It is senseless that Congress has prohibited the Centers for Medicare & Medicaid Services (CMS) from negotiating with pharmaceutical companies to leverage consumer purchasing power to drive down costs. Requiring the CMS to do so would protect sick people from economic predation, while also improving outcomes across our healthcare system.